BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bilbao I, Dopazo C, Lazaro J, Castells L, Caralt M, Sapisochin G, Charco R. Multiple indications for everolimus after liver transplantation in current clinical practice. World J Transplant 2014; 4(2): 122-132 [PMID: 25032101 DOI: 10.5500/wjt.v4.i2.122]
URL: https://www.wjgnet.com/1948-5182/full/v4/i2/122.htm
Number Citing Articles
1
Christophe Duvoux, Christian Toso. mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?Transplantation Reviews 2015; 29(3): 168 doi: 10.1016/j.trre.2015.02.003
2
Jérôme Dumortier, Sebastien Dharancy, Yvon Calmus, Christophe Duvoux, François Durand, Ephrem Salamé, Faouzi Saliba. Use of everolimus in liver transplantation: The French experienceTransplantation Reviews 2016; 30(3): 161 doi: 10.1016/j.trre.2015.12.003
3
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan, Martina Sterneck. Selection and use of immunosuppressive therapies after liver transplantation: current German practiceClinical Transplantation 2016; 30(5): 487 doi: 10.1111/ctr.12708
4
Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas‐Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez‐Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in SpainLiver Transplantation 2015; 21(8): 1056 doi: 10.1002/lt.24172
5
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recomendaciones de uso de everolimus en el trasplante hepáticoGastroenterología y Hepatología 2017; 40(9): 629 doi: 10.1016/j.gastrohep.2017.05.008
6
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recommendations of everolimus use in liver transplantGastroenterología y Hepatología (English Edition) 2017; 40(9): 629 doi: 10.1016/j.gastre.2017.10.006
7
Shin Hwang, Jung-Man Namgoong, Seak Hee Oh, Kyung Mo Kim, Chul-Soo Ahn, Hyunhee Kwon, Yu Jeong Cho, Yong Jae Kwon. Effect of everolimus rescue therapy for acute cellular rejection following pediatric living donor liver transplantation: Report of one caseAnnals of Hepato-Biliary-Pancreatic Surgery 2020; 24(2): 216 doi: 10.14701/ahbps.2020.24.2.216
8
O. A. Gerasimova, D. A. Granov, F. K. Zherebtsov. Everolimus in clinical practice after liver transplantation: a single-center experienceRussian Journal of Transplantology and Artificial Organs 2017; 19(2): 34 doi: 10.15825/1995-1191-2017-2-34-40
9
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approachesNature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193